342 filings
8-K
ARIA
ARIAD Pharmaceuticals Inc
16 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
6 Feb 17
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
10 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
8 Dec 16
Other Events
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
7 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
85xzxno zu
30 Nov 16
Other Events
12:00am
8-K
cb9g513ttuvt
18 Nov 16
ARIAD Announces Data Presentations at the World Conference on Lung Cancer
12:00am
8-K
6ik77 oja0di92by9w
7 Nov 16
ARIAD Reports Third Quarter 2016 Financial Results
12:00am
8-K
1lk3pn8e
31 Oct 16
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
12:00am
8-K
8fb0z 63n7
29 Sep 16
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
12:00am
8-K
helvkc8
30 Aug 16
ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration
12:00am
8-K
endoxvly
28 Jul 16
ARIAD Reports Second Quarter and First Half 2016 Financial Results
12:00am
8-K
1yg5 3m1h
22 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
1vbusob7u
7 Jun 16
Other Events
12:00am
8-K
xgjbs4m najithki1cn
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
cgtce7l1 twyvxrb
26 May 16
Ariad Announces Appointment of Jennifer L. Herron
12:00am
8-K
su60e5
20 May 16
Departure of Directors or Certain Officers
12:00am
8-K
ccy0tj9 pncq
19 May 16
ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting
12:00am
8-K
27g2a lak3
10 May 16
ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review
12:00am
8-K
4ny47qatpl 9alq7anw5
9 May 16
Incyte and Ariad Announce Agreement for Incyte to Acquire
12:00am